The dawn of the lasers?
With technology moving forward apace across every other sector of the healthcare industry, it only makes sense that dentistry would see comparable advances.
While crowns, bridges and models – both dental and orthodontic – have historically been created with an approach that is typically expensive, painstaking and time-consuming, 3D printing is starting to take hold across the industry and consequently ensuring that mirrors and plaster moulds are becoming a thing of the past. Similarly, in dental surgeries, dental lasers are becoming increasingly popular with the market projected to reach $236 million by 2022.
Oxfordshire-based Byrnes Dental Lab is the only company of its kind in Europe to own a Carbon M2 DLS system – one of the leading industrial 3D printers –and sung its praises in an interview with trade magazine TCT:
“Suddenly, all models were exactly the same, they were 100 per cent reproducible, the cleaning was quick, it was easy, it wasn’t messy. We could quadruple our volume with no additional stress. In fact, it reduced the pressure on the team.”
After continued success, Managing Director Ashley Byrne was so taken by the Carbon machine that he purchased a second to keep up with demand. He said: “Everything is reproducible when it’s digital. It’s better for the patient, it’s better for the dentist, and it’s better for us.”
In the surgery, however, 3D printing is not the only emergent technology changing the face of dentistry.
US news aggregation site Comtex reported in September last year that the dental lasers market is projected to reach $236 million by the year 2022. There are key players operating across North America, Japan and the Middle East, but the sector only seems set to grow across the world.
Their market report states that this growth will come as a result of lasers’ ease of use and capacity for control. Consequently, traditionally difficult or intrusive surgeries may well become far more straightforward and streamlined than ever before.
According to a report published by Future Markets Insights on the 13th of February, the market could reach $409 million by 2026 and is predicted to grow by 4.5 per cent in 2019. The market is dominated by a few key firms, with Biolase reported to have a 53 per cent market share.